136 related articles for article (PubMed ID: 26057602)
1. BHRF1 exerts an antiapoptotic effect and cell cycle arrest via Bcl-2 in murine hybridomas.
Milián E; Prats E; Cairó JJ; Gòdia F; Vives J
J Biotechnol; 2015 Sep; 209():58-67. PubMed ID: 26057602
[TBL] [Abstract][Full Text] [Related]
2. Expression of BHRF1 improves survival of murine hybridoma cultures in batch and continuous modes.
Juanola S; Vives J; Milián E; Prats E; Cairó JJ; Gòdia F
Appl Microbiol Biotechnol; 2009 May; 83(1):43-57. PubMed ID: 19139878
[TBL] [Abstract][Full Text] [Related]
3. Inducible expression of Bcl-XL restricts apoptosis resistance to the antibody secretion phase in hybridoma cultures.
Jung D; Côté S; Drouin M; Simard C; Lemieux R
Biotechnol Bioeng; 2002 Jul; 79(2):180-7. PubMed ID: 12115434
[TBL] [Abstract][Full Text] [Related]
4. EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.
Fitzsimmons L; Cartlidge R; Chang C; Sejic N; Galbraith LCA; Suraweera CD; Croom-Carter D; Dewson G; Tierney RJ; Bell AI; Shannon-Lowe C; Herold MJ; Rickinson AB; Colman PM; Huang DCS; Strasser A; Kvansakul M; Rowe M; Kelly GL
Cell Death Differ; 2020 May; 27(5):1554-1568. PubMed ID: 31645677
[TBL] [Abstract][Full Text] [Related]
5. Functional differences between BHRF1, the Epstein-Barr virus-encoded Bcl-2 homologue, and Bcl-2 in human epithelial cells.
Dawson CW; Dawson J; Jones R; Ward K; Young LS
J Virol; 1998 Nov; 72(11):9016-24. PubMed ID: 9765446
[TBL] [Abstract][Full Text] [Related]
6. Effect of HA14-1 on apoptosis-regulating proteins in HeLa cells.
Rehman K; Tariq M; Akash MS; Gillani Z; Qazi MH
Chem Biol Drug Des; 2014 Mar; 83(3):317-23. PubMed ID: 24118733
[TBL] [Abstract][Full Text] [Related]
7. BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates.
Khanim F; Dawson C; Meseda CA; Dawson J; Mackett M; Young LS
J Gen Virol; 1997 Nov; 78 ( Pt 11)():2987-99. PubMed ID: 9367386
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death.
Henderson S; Huen D; Rowe M; Dawson C; Johnson G; Rickinson A
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8479-83. PubMed ID: 8397406
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MCL-1 by obatoclax sensitizes Sp2/0-Ag14 hybridoma cells to glutamine deprivation-induced apoptosis.
Harnett CC; Abusneina A; Clément J; Gauthier ER
Cell Biochem Funct; 2015 Jul; 33(5):334-40. PubMed ID: 26178811
[TBL] [Abstract][Full Text] [Related]
10. Dependence of granzyme B-mediated cell death on a pathway regulated by Bcl-2 or its viral homolog, BHRF1.
Davis JE; Sutton VR; Smyth MJ; Trapani JA
Cell Death Differ; 2000 Oct; 7(10):973-83. PubMed ID: 11279544
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of viral homologues of bcl-2 on hybridoma cells under apoptosis-inducing conditions.
Vives J; Juanola S; Cairó JJ; Prats E; Cornudella L; Gòdia F
Biotechnol Prog; 2003; 19(1):84-9. PubMed ID: 12573010
[TBL] [Abstract][Full Text] [Related]
12. BHRF1, a viral homologue of the Bcl-2 oncogene, disturbs epithelial cell differentiation.
Dawson CW; Eliopoulos AG; Dawson J; Young LS
Oncogene; 1995 Jan; 10(1):69-77. PubMed ID: 7824280
[TBL] [Abstract][Full Text] [Related]
13. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2.
Hickish T; Robertson D; Clarke P; Hill M; di Stefano F; Clarke C; Cunningham D
Cancer Res; 1994 May; 54(10):2808-11. PubMed ID: 8168114
[TBL] [Abstract][Full Text] [Related]
15. The Epstein-Barr virus gene BHRF1, a homologue of the cellular oncogene Bcl-2, inhibits apoptosis induced by gamma radiation and chemotherapeutic drugs.
McCarthy NJ; Hazlewood SA; Huen DS; Rickinson AB; Williams GT
Adv Exp Med Biol; 1996; 406():83-97. PubMed ID: 8910674
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells.
Hao JH; Yu M; Liu FT; Newland AC; Jia L
Cancer Res; 2004 May; 64(10):3607-16. PubMed ID: 15150119
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of myelomonocytic leukemia U937 cells to the induction of apoptosis by the non-peptidic Bcl-2 ligand HA14-1 is cell cycle phase-dependent.
Reiners JJ; Kessel D
Cancer Lett; 2005 Apr; 221(2):153-63. PubMed ID: 15808401
[TBL] [Abstract][Full Text] [Related]
18. Human cellular protein VRK2 interacts specifically with Epstein-Barr virus BHRF1, a homologue of Bcl-2, and enhances cell survival.
Li LY; Liu MY; Shih HM; Tsai CH; Chen JY
J Gen Virol; 2006 Oct; 87(Pt 10):2869-2878. PubMed ID: 16963744
[TBL] [Abstract][Full Text] [Related]
19. Regulation of HA14-1 mediated oxidative stress, toxic response, and autophagy by curcumin to enhance apoptotic activity in human embryonic kidney cells.
Ranjan K; Sharma A; Surolia A; Pathak C
Biofactors; 2014; 40(1):157-69. PubMed ID: 23559532
[TBL] [Abstract][Full Text] [Related]
20. The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type.
Foghsgaard L; Jäättelä M
J Virol; 1997 Oct; 71(10):7509-17. PubMed ID: 9311830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
